Skip to content

Integra Lifesciences Holdings Corp (IART) stock: revenue, earnings & dividend

Integra Lifesciences Holdings Corp (IART, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener IART · Nasdaq Medizintechnik & Messgeräte US-NJ

Key figures

Fiscal year
2025
Revenue
1.64 bn $
Revenue growth
1.5 %
Revenue growth 5y (p.a.)
3.6 %
Net income
-516.8 m $
Net margin
-31.6 %
Operating margin
-30.2 %
Earnings per share (diluted)
-6.74 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
3.6 bn $
Equity
1.04 bn $
Equity ratio
29 %
Return on equity
-49.5 %
Cash
235 m $
Operating cash flow
50.4 m $
Free cash flow
-31.05 m $
Shares outstanding
77,800,976

History

Revenue by fiscal year

2016 992 m $
2017 1.19 bn $
2018 1.47 bn $
2019 1.52 bn $
2020 1.37 bn $
2021 1.54 bn $
2022 1.56 bn $
2023 1.54 bn $
2024 1.61 bn $
2025 1.64 bn $

Net income by fiscal year

2016 74.6 m $
2017 64.7 m $
2018 60.8 m $
2019 50.2 m $
2020 134 m $
2021 169 m $
2022 181 m $
2023 67.7 m $
2024 -6.9 m $
2025 -516.8 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.64 bn $-516.8 m $-6.74 $–50.4 m $
20241.61 bn $-6.9 m $-0.09 $–129 m $
20231.54 bn $67.7 m $0.84 $–140 m $
20221.56 bn $181 m $2.16 $–264 m $
20211.54 bn $169 m $1.98 $–312 m $
20201.37 bn $134 m $1.57 $–204 m $
20191.52 bn $50.2 m $0.58 $–231 m $
20181.47 bn $60.8 m $0.72 $–200 m $
20171.19 bn $64.7 m $0.82 $–115 m $
2016992 m $74.6 m $0.94 $–116 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)